Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05914987
What this trial is testing

Determining Individualized Cancer Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Medical College of Wisconsin 1,000
Not applicableNo Longer AvailableNCT04137822
What this trial is testing

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic CancerPancreatic Cancer Stage IV+1 more
Impatients N.V. trading as myTomorrows
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Not applicableStudy completedNCT03187028
What this trial is testing

Diet and Exercise After Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Alabama at Birmingham 15
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Early research (Phase 1)Ended earlyNCT00783172
What this trial is testing

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Milton S. Hershey Medical Center 4
Large-scale testing (Phase 3)Ended earlyNCT01956812
What this trial is testing

Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic Cancer
Gilead Sciences 334
Testing effectiveness (Phase 2)UnknownNCT03662412
What this trial is testing

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Large-scale testing (Phase 3)UnknownNCT02854072
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Samsung Pharmaceutical Co., Ltd. 148
Not applicableUnknownNCT01522573
What this trial is testing

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Who this might be right for
CholangiocarcinomaPancreatic CancerBile Duct Cancer+11 more
Weill Medical College of Cornell University 1,000
Not applicableStudy completedNCT00628186
What this trial is testing

Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy

Who this might be right for
Pancreatic CancerBile Duct CancerAmpullary Cancer+2 more
Wakayama Medical University 100
Not applicableWithdrawnNCT06554730
What this trial is testing

MSD Belzutifan PAS

Who this might be right for
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01977066
What this trial is testing

Exercise Intervention Study for Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
German Cancer Research Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT07478523
What this trial is testing

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Who this might be right for
CholangiocarcinomaPancreatic Adenocarcinoma
University Hospital, Bordeaux 120
Large-scale testing (Phase 3)UnknownNCT01065870
What this trial is testing

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Who this might be right for
Pancreatic Cancer Stage IIPancreatic Cancer Stage III
Columbia University 64
Not applicableStudy completedNCT03513705
What this trial is testing

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

Who this might be right for
Carcinoma, Pancreatic Ductal
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 4,000
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404595
What this trial is testing

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Who this might be right for
Gastric CancerPancreatic Cancer
CARsgen Therapeutics Co., Ltd. 110
Not applicableLooking for participantsNCT04095195
What this trial is testing

Registry of Subjects at Risk of Pancreatic Cancer

Who this might be right for
Familial Pancreatic CancerBRCA1 MutationBRCA2 Mutation+4 more
Associazione Italiana per lo Studio del Pancreas 1,000
Next Page